Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Voice Disorders 1Squamous Cell Carcinoma of Head and Neck 1Non-Muscle Invasive Bladder Neoplasms 1Laryngeal Neoplasms 1Head and Neck Neoplasms 1Arthralgia 1

Interventions

Therapeutics 1Testosterone 1Surveys and Questionnaires 1Letrozole 1Hyaluronic Acid 1Glucosamine 1Glucaric Acid 1Chondroitin Sulfates 1Chondroitin 1Cholecalciferol 1Cannabidiol 1Calcium Gluconate 1Calcium Citrate 1Calcium Carbonate 1Calcium 1Aromatase Inhibitors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Arthralgia × Hyaluronic Acid × Clear all
NCT03384095 2019-01-02

Trial of Oral Hyaluronic Acid for the Prevention of Aromatase Inhibitor-Associated Arthralgias

Indiana University

Phase 2 Withdrawn

Arthralgia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡